Lozano Blesa University Clinical Hospital

November 28, 2024

Daniel Orós López: “The secret is not just having ideas, it is making them a reality”

In this interview, the IIS Aragón researcher talks about his work leading the Placental Pathophysiology and Fetal Programming Group (GIIS028) and the profiles that comprise it.
November 19, 2024

Dolores Isla, IP of the IIS Aragón: “Spain is a leader in participation in clinical trials for lung cancer”

On the occasion of World Lung Cancer Day, ConSalud.es interviews Dr. Dolores Isla, IP of the Medical Oncology group at the Lozano Blesa Clinical Hospital (GIIS025) of the IIS Aragón and president of the Association for Lung Cancer Research in Women.
October 29, 2024

Presentation of the 'FarmaSonda App': Innovation in Clinical Nutrition

On Thursday, October 24, the IIS Aragón, the Lozano Blesa University Clinical Hospital and Nestlé Health Science presented the tool that allows health professionals to check the compatibility of medication for patients with nutritional administration by gastrostomy or nasogastric tube.
Augusts 12, 2024

The Hematology Research Group at HCU Lozano Blesa performs the first apheresis for CART therapy in Aragon

The IIS Aragón research group has been accredited for this process, the first part of these innovative therapies. CART therapy is increasingly being established as a treatment for hematological tumors, mainly lymphomas.
28 June, 2024

Expert health professionals from Aragon evaluate the challenges in the approach and management of Hidradenitis Suppurativa

The session, organized by the IIS Aragón together with the collaboration of Novartis, has addressed the challenges faced by the Aragonese health system in the management of Hidradenitis Suppurativa (HS).
24 June, 2024

Vitamin D deficiency is an “unreal pandemic” and there is a solution

A study by the Aragón Health Research Institute (IIS Aragón) at the Lozano Blesa Clinical Hospital with direct and indirect methods indicates that the cut-off value should be updated to 12 ng/ml